3 ms·
It's an interesting matter. Numbers should be seen. I have not followed the data, but a quick search reveals a few articles are available, for example: Reinfec
by mdp2021 5y ago
It's an interesting matter. Numbers should be seen. I have not followed the data, but a quick search reveals a few articles are available, for example:
Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study [Mar 2021]
https://pubmed.ncbi.nlm.nih.gov/33718968/ https://pubmed.ncbi.nlm.nih.gov/33718968/
> Of 150,325 patients, 8,845 (5.9%) tested positive and 141,480 (94.1%) tested negative prior to August 30. 1,278 (14.4%) of the positive patients were retested after 90 days, and 62 had possible reinfection. Of those, 31 (50%) were symptomatic. Of those with initial negative testing, 5,449 (3.9%) were subsequently positive and 3,191 of those (58.5%) were symptomatic. Protection offered from prior infection was 81.8% (95% confidence interval 76.6 to 85.8), and against symptomatic infection was 84.5% (95% confidence interval 77.9 to 89.1). This protection increased over time
The literature should be checked to see the different estimates of different researches.
--
Edit: those results seem consistent with my second in queue article,
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021
https://www.cdc.gov/mmwr/volumes/70/wr/mm7032e1.htm https://www.cdc.gov/mmwr/volumes/70/wr/mm7032e1.htm
since
> being unvaccinated was associated with 2.34 times the odds of reinfection compared with being fully vaccinated
Those studies show a good amount of post infection protection, though lower than some relevant vaccines. Also duration of the protection should be factored in, and the consideration is ongoing: only a few hours ago I read material (an Axios summary) about Pfizer vs Moderna,
https://www.axios.com/pfizer-moderna-coronavirus-vaccines-effectiveness-data-4a681617-d887-4b21-93a3-d6c2d9d51b31.html https://www.axios.com/pfizer-moderna-coronavirus-vaccines-ef...